HeplerCDStrandLM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm1990; 47: 533–43.
2.
FarrisKBKirkingDM. Assessing the quality of pharmaceutical care I. One perspective of quality. Ann Pharmacother1993; 27: 68–73.
3.
FarrisKBKirkingDM. Assessing the quality of pharmaceutical care II. Application of concepts of quality assessment from medical care. Ann Pharmacother1993; 27: 215–23.
4.
AlbersGWYimJMBelewKMBittarNHattemerCRPhillipsBG. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med1996; 156: 2311–6.
5.
AlbersGWYimJBittarNYoungKHattemerCRGhandiAJ. Clinical characteristics and management of acute stroke in atrial fibrillation patients in US university hospitals. Neurology1997; 48: 1598–604.
6.
PhillipsBGYimJMBrownEJBittarNHoonTJCelestinC. Treatment of acute myocardial infarction at United States academic hospitals. Am Heart J1996; 131: 872–8.
7.
YimJMHoonTJBittarNPhillipsBGBrownEJCelestinC. Angiotensin-Converting enzyme inhibitor use in survivors of acute myocardial infarction. Am J Cardiol1995; 75: 1184–6.
8.
SoumeraiSBMcLaughlinTJSpiegelmanDHertzmarkEThibaultGGoldmanL. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA1997; 277: 115–21.
9.
MunschauerFEPrioreRLHensMCastiloneA. Thromboembolism prophylaxis in chronic atrial fibrillation. Stroke1997; 28: 72–6.
10.
GoldsteinS. Beta-blockers in hypertensive and coronary heart disease. Arch Intern Med1996; 156: 1267–74.
11.
LinnWD. Angiotensin-Converting enzyme inhibitors in left ventricular dysfunction. Pharmacotherapy1996; 16 (suppl): 50S–8S.
12.
HartertTVWindomHHPeeblesRSJr. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med1996; 100: 386–94.
13.
Gonzalez-RothiRJ. Tuberculosis chemoprophylaxis and physicians. Chest1995; 108: 596–7.
14.
La RosaJC. Cholesterol-lowering and the cost-effective prevention of recurrent coronary disease. Cardiovasc Rev Rep1996; 17: 1–10.
15.
FrancisDP. The public's health unprotected — reversing a decade of underutilization of hepatitis B vaccine. JAMA1995; 274: 1242–3.
16.
KumarSSchefflerSSingletonSLawrenceM. Influenza immunization rates for Louisiana Medicare beneficiaries (1993–1995): a need for interventions. J La State Med Soc1996; 148: 423–9.
